日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Circulating protein biomarkers of physical fitness associated with cardiometabolic risk in women after gestational diabetes: a PONCH study

妊娠期糖尿病后女性心血管代谢风险相关的循环蛋白生物标志物与体能的关系:一项PONCH研究

Kristiansson, Emilia; Holmäng, Agneta; Wallenius, Kristina; Chung, H Sophia; Hess, Sonja; Pettersson, Stefan; Madsen, Klavs; Andersson-Hall, Ulrika

Longitudinal clinical and proteomic diabetes signatures in women with a history of gestational diabetes

妊娠糖尿病史女性的纵向临床和蛋白质组学糖尿病特征

Chung, Heaseung Sophia; Middleton, Lawrence; Garg, Manik; Hristova, Ventzislava A; Vega, Rick B; Baker, David; Challis, Benjamin G; Vitsios, Dimitrios; Hess, Sonja; Wallenius, Kristina; Holmäng, Agneta; Andersson-Hall, Ulrika

Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist

ECC5004/AZD5004 是一种新型每日一次口服小分子 GLP-1 受体激动剂,对其进行非临床和首次人体表征。

Haggag, Amina Z; Xu, Jianfeng; Butcher, Laurie; Pagnussat, Sandra; Davies, Graeme; Lundqvist, Sara; Wang, Wenyu; Van Zuydam, Natalie; Nelander, Karin; Jha, Aruni; Yu, Hongtao; Boianelli, Alessandro; Lindmark, Bosse; Ollerstam, Anna; Sun, Xuefeng; Wang, Fan; Pan, Xiaoliang; Liu, Haihui; Chen, Wengang; Xu, Jianfeng; Wallenius, Kristina; Zhou, Jingye

Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism

敲除酮己糖激酶与抑制其激酶活性对果糖代谢产生截然不同的影响。

Park, Se-Hyung; Fadhul, Taghreed; Conroy, Lindsey R; Clarke, Harrison A; Sun, Ramon C; Wallenius, Kristina; Boucher, Jeremie; O'Mahony, Gavin; Boianelli, Alessandro; Persson, Marie; Jung, Sunhee; Jang, Cholsoon; Loria, Analia S; Martinez, Genesee J; Kipp, Zachary A; Bates, Evelyn A; Hinds, Terry D Jr; Divanovic, Senad; Softic, Samir

Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.

FGF21 药物治疗可显著改善血浆胆固醇代谢,从而减少动脉粥样硬化

Liu Cong, Schönke Milena, Zhou Enchen, Li Zhuang, Kooijman Sander, Boon Mariëtte R, Larsson Mikael, Wallenius Kristina, Dekker Niek, Barlind Louise, Peng Xiao-Rong, Wang Yanan, Rensen Patrick C N

The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis

SGLT2抑制剂达格列净可促进全身游离脂肪酸动员,增强肝脏β-氧化,并诱导酮症。

Wallenius, Kristina; Kroon, Tobias; Hagstedt, Therese; Löfgren, Lars; Sörhede-Winzell, Maria; Boucher, Jeremie; Lindén, Daniel; Oakes, Nicholas D

Identification of Proteins Associated with the Early Restoration of Insulin Sensitivity After Biliopancreatic Diversion

胆胰分流术后早期恢复胰岛素敏感性相关蛋白的鉴定

Karlsson, Cecilia; Wallenius, Kristina; Walentinsson, Anna; Greasley, Peter J; Miliotis, Tasso; Hammar, Mårten; Iaconelli, Amerigo; Tapani, Sofia; Raffaelli, Marco; Mingrone, Geltrude; Carlsson, Björn

Involvement of the metabolic sensor GPR81 in cardiovascular control

代谢传感器GPR81参与心血管控制

Wallenius, Kristina; Thalén, Pia; Björkman, Jan-Arne; Johannesson, Petra; Wiseman, John; Böttcher, Gerhard; Fjellström, Ola; Oakes, Nicholas D

The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat

PPARα/γ激动剂Tesaglitazar可改善肥胖Zucker大鼠体内胰岛素介导的组织葡萄糖和游离脂肪酸利用转换。

Wallenius, Kristina; Kjellstedt, Ann; Thalén, Pia; Löfgren, Lars; Oakes, Nicholas D